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RESEARCH ARTICLE
Commonest Cancers in Pakistan - Findings and Histopathological
Perspective from a Premier Surgical Pathology Center in
Pakistan
Zubair Ahmad, Romana Idrees*, Saira Fatima, Nasir Uddin, Arsalan Ahmed,
Khurram Minhas, Aisha Memon, Syeda Samia Fatima, Muhammad Arif, Sheema
Hasan, Rashida Ahmed, Shahid Pervez, Naila Kayani
Abstract
Context: There are no recent authoritative data about incidence and prevalence of various types of cancers in
Pakistan. Aim: To determine the frequency of malignant tumors seen in our practice and provide a foundation
for building a comprehensive cancer care strategy. Materials and Methods: 10,000 successive cases of solid
malignant tumors reported in 2014 were included. All cases had formalin fixed, paraffin embedded specimens
available and diagnosis was based on histological examination of H&E stained slides plus ancillary studies at the
Section of Histopathology, Department of Pathology and Laboratory Medicine, Aga Khan University Hospital,
Karachi. The latest WHO classifications were used along with the latest CAP protocols for reporting and the most
updated TNM staging. Results: There were 9,492 (94.9%) primary tumors while 508 (5.1%) were metastatic.
Some 5,153 (51.5%) were diagnosed in females and 4,847 (48.5%) in males. The commonest malignant tumors
in females were breast (32%), esophagus (7%), lymphomas (6.8%), oral cavity (6.7%) and ovary (4.8%), while
in males they were oral cavity (13.9%), lymphomas (12.8%), colorectum (7.9%), stomach (6.9%) and esophagus
(6.6%). Malignant tumors were most common in the 5th, 6th and 7th decades. About 8% were seen under 20
years of age. Conclusions: Oral cavity and gastrointestinal cancers continue to be extremely common in both
genders. Breast and esophageal cancers are prevalent in females. Lung and prostate cancer are less common
than in the west. Ovarian cancer was very common but cervix cancer was less so.
Keywords: Cancer - carcinoma - lymphoma - sarcoma - decade-wise age data - histological types
Asian Pac J Cancer Prev, 17 (3), 1061-1075

Introduction
We are the biggest center for Histopathology in
Pakistan, a country of over 180 million people, and
receive cases from all over the country. Last year, we
reported over 57,000 surgical pathology and over 18,000
cytology specimens. We are a major referral center for
difficult and challenging cases from all over the country
and malignant tumors constitute a major chunk of our
practice. Since we receive cases from all over Pakistan,
frequencies of various malignant tumors in our practice
are a fair indication of their frequency in Pakistan. Even
today, there is no ‘cancer registry’ in Pakistan and there
is no definite data regarding the incidence of various
cancers. This state of affairs is very depressing since
cancer takes a heavy toll of human life in this extremely
populous country and incurs a huge cost in terms of
morbidity and mortality. The majority of the people are

poor, and have little access to even basic necessities of
life. Not only are accurate figures regarding the incidence
and prevalence of cancers unknown, the diagnosis and
management of malignant tumors is extremely suboptimal
(in terms of facilities, qualified physicians, therapeutic
options etc.). The majority of patients cannot afford the
cost of treatment. Cancer patients often die painful and
miserable deaths. Little to no facilities are available in
remote areas and people need to travel to larger cities in
order to get treatment which is very expensive. Although
the government and private sector have taken a number
of initiatives to improve cancer care in the country, the
overall situation remains bleak.
An important step in achieving better cancer care
is to determine the incidence of various cancers in the
country. A pathology department cannot accurately
determine cancer incidence. However, being the busiest
histopathology department in the country receiving cases
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from all over Pakistan, we can provide a fair assessment
of the frequency of various cancers in Pakistan.
The aim of this study was to determine the frequency
of various cancers in Pakistan based on our practice. This
data will hopefully provide a foundation which can help
in building an accurate cancer registry and developing a
comprehensive cancer care strategy.

specimens. Only tumors fulfilling well defined criteria
for malignancy were included. Borderline tumors such
as borderline ovarian neoplasms or borderline phylloides
tumor of breast were not included. Giant cell tumor of
the bone, borderline histiocytomas (dermatofibrosarcoma
protuberans), and locally aggressive conditions such as
fibromatosis were not included. Gastrointestinal (including
pancreatobiliary) neuroendocrine tumors (NETs) were
included. Low grade appendiceal mucinous neoplasms
(LAMNs) and low grade pseudomyxoma peritonei were
excluded. All grade II and higher Central Nervous System
(CNS) neoplasms were included. However, grade I CNS
tumors such as pilocytic astrocytoma, grade I meningioma,
myxopapillary ependymoma etc were not included. In all
cases, diagnosis was based on microscopic examination

Materials and Methods
A total of 10,000 successive cases of malignant
tumors reported in the Section of Histopathology, AKUH
in the year 2014 were included in the study. Only solid
tumors were included, leukemias were excluded. All
cases included were formalin fixed, paraffin embedded

Table 1. Malignant Tumors in Males and Females Combined (n=10,000)
S.
No
#
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

Females
Total
Percentage Males Total
No.
(%)
No. (4847)
(5153)
1650
32.0%
345
6.7%
676

"Over all
Total No.”

Percentage
(%)

Breast Cancer
Oral cavity Carcinoma*

1650
1021

16.5%
10.2%

Non Hodgkin Lymphoma Nodal
Non Hodgkin Lymphoma Extranodal
Hodgkin Lymphoma
Esophageal Carcinoma
Colorectal Carcinoma
Skin Carcinoma
Gastric Carcinoma
Lung Carcinoma
CNS Malignant Tumor**
Urinary bladder Carcinoma
Larynx and vocal cord carcinoma
Ovarian Carcinoma
Prostate Carcinoma
Endometrial Carcinoma
Cervix Carcinoma
Thyroid Carcinoma
Renal carcinoma
Ewing Sarcoma
Gall bladder carcinoma
Testicular malignant Tumors
Ampullary, Periamapullary, pancreatic,
Small intestine Carcinoma
Salivary gland malignancies
Osteosarcoma
Liver carcinoma
Pleomorphic Sarcoma
Leiomyosarcoma
Synovial Sarcoma
Plasma cell Neoplasm
Nose, Paranasal sinuses, nasopharynx
carcinoma
Metastatic Tumors
Miscellaneous malignant Tumor

(375)
(358)
(241)
680
595
489
475
380
356
325
270
248
237
187
140
137
123
119
104
102

6.8%
5.9%
4.9%
4.7%
3.8%
3.6%
3.2%
2.7%
2.5%
2.4%
4.8%
1.4%
1.4%
1.2%
1.2%
1.04%
1.02%

(130)
(126)
(96)
362
211
201
139
77
117
80
105
248
187
140
91
43
56
75
-

102

1.02%

88
86
82
61
57
53
43

Organ and tumor Type

Lymphoma

974

9.7%

352

6.8%

622

13.9%
12.8%

7.0%
4.1%
3.9%
2.7%
1.5%
2.3%
1.5%
2.0%
4.8%
3.6%
2.7%
1.8%
0.8%
1.1%
1.4%
-

(245)
(232)
(145)
318
384
288
336
303
239
245
165
237
46
80
64
29
102

38

0.7%

64

1.3%

0.9%
0.86%
0.8%
0.6%
0.57%
0.5%
0.4%

33
34
35
20
21
24
15

0.6%
0.6%
0.7%
0.4%
0.4%
0.5%
0.3%

55
52
47
41
36
29
28

1.2%
1.1%
1.0%
0.8%
0.7%
0.6%
0.6%

43

0.4%

20

0.4%

23

0.5%

508
264

5.1%
2.6%

264
170

5.1%
3.3%

244
94

5.0%
1.9%

*Includes lip, tongue, floor of mouth, buccal mucosa, hard palate, upper and lower gingiva; **Central Nervous System (CNS)
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6.3%
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2.1%
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of Hematoxylin and Eosin (H&E) stained slides. Special
stains e.g. Periodic Acid Schiff Alcian Blue ± diastase,
reticulin etc. were performed whenever required. A large
panel of Immunohistochemical stains (IHC) was utilized
whenever necessary to reach a conclusive diagnosis.
IHC was used in all cases of Hodgkin and Non Hodgkin
lymphomas. The latest WHO classifications were used.
Resection specimens were reported in strict accordance
with the latest College of American Pathologists (CAP)
protocols(Washington, 2013) and staged according to
the most updated TNM classifications.(Edge et al., 2010)
All relevant data was recorded and analysed using
the SPSS 19.0 software package. p-values for different
variables were calculated using the Chi Square and
Fisher Axact tests. p-value equal to or less than 0.05 was
considered significant.

Results
A total of 10,000 consecutive cases of malignant solid
tumors diagnosed in the Section of Histopathology, AKUH
in 2014 were included. Out of these, 9492 (94.9%) were
primary tumors while 508 (5.1%) were metastatic tumors.
Out of 10,000, 5153 (51.5%) tumors were diagnosed in

females and 4847 (48.5%) in males. The overall breakup
is shown in Table 1. The decade wise breakup of the
commonest malignant tumors in females and males is
shown in Tables 2 and 3 respectively. The decade wise
breakup of all 10,000 malignant tumors is shown in
Table 4.
Breast carcinoma was the commonest malignant
tumor in females (32%). Out of 1650 cases, 685 (41.5%)
involved the right breast, 787 (47.7%) involved the left
and 26 (1.6%) were bilateral. In 152 cases (9.2%), the
laterality was not known. The decade wise breakup is
shown in Table 2, while frequency of various histologic
types is shown in Table 5. Invasive Ductal Carcinoma,
NOS was the commonest histologic type comprising
1427 cases (86.5%), this value was statistically significant
(p-value: <0.0001).
Cancer of the oral cavity was overall the second
commonest type of malignant tumor (Table 1). Out of a
total of 1021 cases, 676 (66.2%) occurred in males while
345 (33.8%) occurred in females. M:F ratio was 1.95:1.
The p-value (<0.0001) was statistically significant. Cancer
of the oral cavity included cancer of the buccal (cheek)
mucosa, floor of mouth, lip, tongue, hard palate and
oropharynx (hypopharynx). All cases were histologically

Table 2. Decade-wise Age Distribution of Commonest Malignant Tumors in Females (n=5153)
Age
Breast
Range
(n=1650)
in years

Oral
(n=345)

NHL Nodal
(n=130)

NHL
Extranodal
(n=126)

HL
Esophagus Stomach Colorectum
Skin (n=201)
(n=96)
(n=362) (n=139)
(n=211)

8
(8.3%)
27
11-20
7 (0.4%) 3 (0.9%) 18 (13.8%)
11 (8.7%)
10 (2.8%)
(28.1%)
148
15
17
17
46
21-30
14 (10.8%)
(9.0%)
(4.3%)
(13.5%) (17.3%) (12.7%)
359
50
15
53
31-40
14 (10.8%) 15 (11.9%)
(21.7%) (14.5%)
(15.6%) (14.6%)
525
99
16
104
41-50
20 (15.4%)
29 (23%)
(31.8%) (28.7%)
(16.7%) (28.7%)
345
92
27
6
77
51-60
34 (26.1%)
(20.9%) (26.7%)
(21.4%)
(6.2%)
(21.3%)
186
53
20
6
57
61-70
19 (14.6%)
(11.3%) (15.4%)
(15.9%)
(6.2%)
(15.7%)
33
1
>70
80 (4.8%)
8 (6.1%)
15 (4.1%)
(9.6%)
(1.0%)
Age
U.
Ewing
Ovary Endometrium Thyroid
Cervix
Range
Bladder
Sarcoma
(n=248)
(n=187)
(n=91)
(n=140)
in years (n=80)
(n=56)
10
0-10
6 (2.4%)
(17.8%)
24
29
11-20
11 (12.1%)
(9.7%)
(51.8%)
43
23
8
12
21-30
2 (2.5%)
12 (6.4%)
(17.3%)
(25.3%)
(5.7%)
(21.4%)
33
23
40
31-40
8 (10%)
11 (5.9%)
5 (8.9%)
(13.3%)
(25.3%) (28.6%)
10
62
14
48
41-50
43 (23%)
(12.5%)
(25%)
(15.4%) (34.3%)
26
38
19
51-60
78 (41.7%) 11 (12.1%)
(32.5%) (15.3%)
(13.6%)
18
36
20
61-70
32 (17.1%)
6 (6.6%)
(22.5%) (14.5%)
(14.3%)
5
>70
16 (20%) 6 (2%)
11 (5.9%)
3 (3.2%)
(3.6%)
0-10

-

-

3 (2.3%)

7 (5.5%)

Lung
(n=77)

CNS
(n=117)
12
(10.2%)
17
(14.5%)
32
(27.4%)
19
(16.2%)
15
(12.8%)

-

-

2 (1.0%)

-

-

11 (5.2%)

2 (1.0%)

-

30 (14.2%)

8 (4.0%)

-

35 (16.6%)

20 (10%)

47 (22.3%)

46 (23%)

54 (25.6%)

49 (24%)

25 (11.8%)

48 (24%)

8 (5.8%)

9 (4.3%)

26 (13%)

G.
Bladder
(n=75)

Salivary
Gland
(n=33)

-

-

6 (17.6%)

-

-

-

2 (6.1%)

20 (58.8%)

-

-

4 (5.3%)

7 (21.2%)

4 (11.8%)

3 (7%)

-

5 (6.7%)

9 (27.3%)

2 (5.9%)

8 (18%)

2 (5.7%)

7 (21.2%)

1 (2.9%)

6 (18.2%)

1 (2.9%)

-

-

2 (6.1%)

-

13
(9.3%)
19
(13.7%)
28
(20.1%)
36
(25.9%)
35
(25.2%)

16
(21.3%)
28
(37.3%)
18
(24%)
4 (5.3%)

10
(13%)
15
(19.5%)
24
11 (9.4%)
(31.2%)
20
10 (8.5%)
(26%)
8
1 (0.8%)
(10.4%)

Osteosarcoma Kidney
(n=34)
(n=43)

Liver
(n=35)

16
6 (17.1%)
(37.2%)
10
14 (40%)
(23.2%)
4
10
(9.3%) (28.6%)
2
3 (8.6%)
(4.6%)
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squamous cell carcinoma of various grades (with 25
cases or 2.4% showing histologic features consistent
with sarcomatoid carcinoma- a histologic variant). The
decade wise breakup is shown in Tables 2 and 3 while
the site wise breakup is shown in Table 6. As shown in
Table 6, oral mucosa was the commonest site for oral
cancers comprising 56.3%. The p-value was statistically
significant (<0.0001).
Lymphoma was the second commonest malignant
tumor in males and the third commonest in females (Table
1). Out of a total of 974 cases, 622 (63.9%) were diagnosed
in males and 352 (36.1%) in females. M:F ratio was 1.76:1.
The p-value was statistically significant (<0.0001). Out of
974 cases, 733 (75.3%) were Non Hodgkin lymphomas
(NHL) while 241 (24.7%) were Hodgkin Lymphomas.
Of the 733 NHLs, 375 (51.2%) were nodal, while 358
(48.8%) were extranodal. The decade wise breakup in
males and females is shown in Tables 2 and 3.
Of the 733 NHLs, 477 (65.1%) were diagnosed in

males, while 256 (34.9%) were diagnosed in females
(Table 1). The p-value was statistically significant
(<0.0001). Of the 375 nodal NHLs, 245 (65.3%) were in
males while 130 (34.7%) were in females. The p-value was
statistically significant (<0.0001). Of the 358 extranodal
NHLs, 232 (64.8%) were in males while 126 (35.2%)
were diagnosed in females. The p-value was statistically
significant (<0.0001). The sites of involvement of
extranodal NHL and the histological types of nodal and
extranodal NHLs are shown in Table 7. Almost 68% of all
extranodal NHLs were Diffuse Large B Cell Lymphoma
(DLBCL). The p-value was statistically significant
(<0.0001).
Out of the 241 cases of Hodgkin lymphoma (HL),
145 (60.2%) were diagnosed in males while 96 (39.8%)
were diagnosed in females. The M:F ratio was 1.51:1.0.
The p-value was statistically significant (<0.0001). The
decade wise breakup is shown in Tables 2 and 3. Mixed
cellularity and nodular sclerosis were the commonest

Table 3. Decade-wise Age Distribution of Commonest Malignant Tumors in Males (n=4847)
Age
Range
in
years

Oral
(n=676)

0-10

-

11-20

4 (0.6%)

21-30
31-40
41-50
51-60
61-70
>70
Age
Range
in
years

72
(10.6%)
119
(17.6%)
183
(27.1%)
166
(24.5%)
84
(12.4%)
48
(7.1%)

NHL
NHL
HL
Esophagus
Nodal Extranodal
(n=145) (n=318)
(n=245) (n=232)
9
16 (6.9%)
(3.7%)
22
37
(9.0%) (15.9%)
21
31
(8.6%) (13.4%)
44
36
(18%)
(15.5%)
51
31
(20.8%) (13.4%)
33
31
(13.5%) (13.4%)
49
40
(20%)
(17.2%)
16
10 (4.3%)
(6.5%)

U.
Larynx
Bladder
(n=165)
(n=245)

Stomach Colorectum
Skin
Lung (n=303)
(n=336)
(n=384)
(n=288)

34
(23.4%)
40
11 (3.5%) 5 (1.5%)
(27.6%)
31
23 (7.2%) 20 (6%)
(21.4%)
12
38
40 (12.6%)
(8.3%)
(11.3%)
11
61
62 (19.5%)
(7.6%)
(18.1%)
97
8 (5.5%) 95 (29.9%)
(28.9%)

22 (9.2%)

40 (10.4%)
77 (20.1%)
76 (19.8%)
82 (21.3%)

Ewing
Sarcoma
(n=36)

G. Bladder
(n=29)

18
(28.6%)
30
(47.6%)

2 (0.8%)

-

1 (2.2%)

-

15 (14.7%)

21-30

3 (1.2%)

-

9 (19.6%) 1 (1.2%) 36 (35.3%) 9 (14.3%)

1064

-

Testis
(n=102)

11-20

>70

4 (1.4%)

Kidney
(n=80)

9 (8.8%)

61-70

16 (4.2%)

Thyroid
(n=46)

-

51-60

22 (9.2%)

28 (7.3%)

-

41-50

-

41
(12.2%)

-

14
(5.7%)
40
(16.3%)
72
(29.4%)
62
(25.3%)
52
(21.2%)

1 (0.3%)

2 (1.4%) 32 (10.1%)

-

31-40

-

7 (4.8%) 55 (17.3%) 74 (22%) 65 (16.9%)

0-10

3
9
7 (15.2%)
27 (26.5%) 2 (3.2%)
(1.8%)
(11.2%)
40
23
7 (15.2%)
8 (7.8%) 2 (3.2%)
(24.2%)
(28.7%)
48
14
24
4 (3.9%) 2 (3.2%)
(29.1%) (30.4%)
(30%)
57
19
6 (13%)
3 (2.9%)
(34.5%)
(23.7%)
17
2 (4%) 5 (6.3%)
(10.3%)
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CNS
(n=239)

14
(4.9%)
39
(13.5%)
47
(16.3%)
74
(25.7%)
63
(21.9%)
46
(16%)

3 (1%)
13 (4.3%)

46
(19.2%)
56
(23.4%)

59 (19.5%)

43 (18%)

85 (28.18%)

26
(10.9%)

100 (30%)

21 (8.8%)

43 (14.2%)

3 (1.2%)

Salivary
Osteosarcoma
Gland
(n=52)
(n=55)

Liver
(n=47)

-

1 (1.8%)

8 (15.4%)

-

-

2 (3.6%)

29 (55.8%)

1 (2.1%)

8 (15.4%)

2 (4.2%)

3 (5.8%)

2 (4.2%)

6
(10.9%)
8
2 (6.8%)
(14.5%)
16
10 (34.5%)
(29.1%)
10
5 (17.2%)
(18.2%)
10
7 (24.1%)
(18.2%)
1 (3.4%)

4 (13.8%)

2 (3.6%)

3 (5.8%)
1 (1.9%)
-

10
(21.3%)
16
(34.1%)
10
(21.3%)
6 (12.8%)
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histologic subtypes comprising 103 (42.7%) and 100
(41.5%) cases respectively. There were 5 cases (2.1%) of
Nodular lymphocyte predominant HL, 4 cases (1.6%) of
lymphocyte rich subtype and 1 case (0.4%) of syncytial
variant. In 28 cases (11.6%), further histologic subtyping
was not possible and a diagnosis of HL, NOS was
rendered.
Esophageal carcinoma was the fourth commonest
malignant tumor overall in both males and females, second
in females and fifth in males. Out of a total of 680 cases,

Table 4. Decade Wise Breakup of All Malignant
Tumors (n=10,000)
Age range (in years)
0-10
20-Nov
21-30
31-40
41-50
51-60
61-70
>70

Number
245
523
902
1421
2169
2235
1733
772

Percentage (%)
2.4%
5.2%
9.0%
14.2%
21.7%
22.3%
17.3%
7.7%

Table 6. Site-wise Distribution of Oral Cavity Cancer
in both Males and Females (n=1021)

Table 5. Frequency of Various Histologic Types Of
Breast Carcinoma and Malignant Ovarian Tumors
in Females
Histologic type

Total No.

Malignant ovarian tumors (n=248)
Papillary serous carcinoma
Endometrioid carcinoma
Mucinous carcinoma
Clear cell carcinoma
Poorly differentiated carcinoma

Percentage
(%)

74
60
20
16
7

29.8%
24.2%
8.1%
6.4%
2.8%

20
13
9

8.1%
5.2%
3.6%

Dysgerminoma

Granulosa cell tumor
Yolk sac tumor
Malignant mixed germ cell tumor
Malignant Sertoli-Leydig cell
tumor
Juvenile granulosa cell tumor
Immature teratoma
Small cell carcinoma
Squamous cell carcinoma arising
in cystic teratoma
Malignant mixed germ cell tumor
Breast carcinomas (n=1650)
Ductal, NOS
Lobular
Metaplastic
Mucinous
Papillary
Medullary
Tubular
Ductolobular
Tubulolobular
Adenoid cystic
Cribriform

11

4.4%

4

1.6%

3
6
2

1.2%
2.4%
0.8%

2

0.8%

1

0.4%

1427
108
51
26
23
4
4
4
1
1
1

86.5%
6.5%
3.1%
1.6%
1.4%
0.2%
0.2%
0.2%
0.06%
0.06%
0.06%

362 (53.2%) were diagnosed in females and 318 (46.8%)
in males. F:M ratio was 1.41:1.0. Of the 680 cases, 442
(65%) were located in the lower third of the esophagus
(statistically significant, p-value: <0.0001), 92 (13.5%) in
the middle third, and 28 (4.1%) in the upper third. In 118
cases (17.3%), exact location was not known. As many
as 660 (97.1%) cases were conventional squamous cell
carcinomas on histologic examination. This value was
statistically significant (p-value: <0.0001). There were 16
(2.3%) adenocarcinomas and 4 (0.6%) cases of basaloid
squamous cell carcinoma. Out of 680, 215 cases (31.6%)
were received from Balochistan province bordering Iran
and China. The decade wise breakup is shown in Tables

Site
Oral (buccal, cheek) mucosa
Tongue
Lip
Floor of mouth
Palate
Oro/hypopharynx
Gum
Not known

Number
575
224
59
58
49
30
10
16

Percentage (%)
56.3%
22%
5.8%
5.7%
4.8%
2.9%
0.9%
1.5%

Table 7. Frequency of various Histologic Types of
Nodal and Extranodal NHL; and Sites of Involvement
of Extranodal NHLs
Sites of involvement of extranodal NHLs (n=358)
Sites of involvement
Total No. Percentage (%)
Stomach
39
10.90%
Colon
32
8.90%
Small intestine
30
8.40%
Bone (predominantly spine)
25
7.00%
Abdomen
19
5.30%
CNS
18
5.00%
Skin
17
4.70%
Tonsil
15
4.20%
Soft tissue
15
4.20%
Oral cavity
14
3.90%
mediastinum
12
3.40%
Nose and nasopharynx
10
2.80%
Face
10
2.80%
Liver
8
2.20%
Retro peritoneum
8
2.20%
Salivary gland
7
1.90%
Lung
6
1.70%
Testis
6
1.70%
Breast
5
1.40%
Female genital tract
5
1.40%
Eye
5
1.40%
Pharynx
5
1.40%
Thyroid
4
1.10%
Mesentery
4
1.10%
Others
16
4.50%
Not known
23
6.40%
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2 and 3.
Colorectal carcinoma was the fifth most common
malignant tumor overall in both males and females.
It was the third most common in males and sixth in
females. Out of a total of 595 cases, 384 (64.5%) were
diagnosed in males and 211 (35.5%) in females. M:F
ratio was 1.8:1.0. This value was statistically significant
(p-value: <0.0001). Of the 595 cases, 448 (75.3%) were
located in the left and 128 (21.5%) in the right colon.
The p-value was statistically significant (<0.0001). In 19
(3.2%) cases, laterality was unknown. All 595 cases were

Table 7 (continued). Frequency of Various Histologic
Types of Nodal and Extranodal NHL; and Sites of
Involvement of Extranodal NHLs
Histological type
Total No. Percentage (%)
Nodal NHL (n=375)
DLBCL*
182
48.50%
CLL /SLL**
51
13.60%
Follicular lymphoma
36
9.60%
Mantle cell lymphoma
19
5.10%
Precursor T cell NHL
18
4.80%
ALCL***
17
4.50%
Precursor B cell NHL
14
3.70%
Burkitt lymphoma
14
3.70%
PTCL****
13
3.50%
Marginal zone lymphoma
5
1.30%
Plasmablastic lymphoma
1
0.30%
NHL, NOS
5
1.30%
"*Diffuse large B cell lymphoma; **Chronic Lymphocytic
Leukemia /Small Lymphocytic Lymphoma; ***Anaplastic
Large Cell Lymphoma; ****Peripheral T Cell Lymphoma"
Extranodal NHL (n=358)
DLBCL*
243
67.90%
Burkitt lymphoma
29
8.10%
PTCL**
16
4.50%
ALCL***
12
3.40%
Pre T ALL****
12
3.40%
Follicular lymphoma
10
2.80%
Extranodal marginal zone
9
2.50%
lymphoma
Pre B ALL
7
1.90%
Mantle cell lymphoma
7
1.90%
MALT lymphoma*****
4
1.10%
Mediastinal B cell lymphoma
2
0.60%
IPSID******
2
0.60%
Hairy cell leukemia
1
0.30%
Angioblastic T cell lymphoma
1
0.30%
Lymphoplasmacytic lym1
0.30%
phoma
Mycosis fungoides
1
0.30%
SLL /CLL*******
1
0.30%
"*Diffuse large B cell lymphoma; **Peripheral T Cell
Lymphoma; ***Anaplastic Large Cell Lymphoma;
****Acute Lymphoblastic Lymphoma; *****Mucosa
Associated Lymphoid Tissue; ******Immunoproliferative
Small Intestinal Disease; *******Chronic Lymphocytic
Leukemia /Small Lymphocytic Lymphoma"
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adenocarcinomas. The large majority were conventional
mucin secreting adenocarcinomas which comprised 566
(95.1%) cases, a value that was statistically significant
(p-value: <0.0001). Of the remaining 29 cases, 15 (2.5%)
showed neuroendocrine differentiation, 10 (1.7%) were
mucinous carcinomas and 4 (0.7%) were signet ring
adenocarcinomas. A total of 535 (89.9%) out of 595 cases
were well to moderately differentiated. The decade wise
breakup is shown in Tables 2 and 3.
A total of 475 cases of gastric carcinoma were
100.0
diagnosed during the study period. Out of these, 336
(70.7%) were in males and 139 (29.3%) in females. M:F
ratio was 2.4:1.0. The value was statistically significant
(p-value: <0.0001). Of the 475 cases, 113 cases (23.8%)
75.0
were located in the proximal and 174 (36.6%) in the distal
stomach. In 28 cases (5.9%), site of biopsy was given as
‘body’. As many as 50 cases (10.5%) were located at the
gastroesophageal junction (GEJ). In 110 cases, (23.1%)50.0
exact location of the tumor was not known. All 475
cases were adenocarcinomas. Of these 7 (1.5%) showed
neuroendocrine differentiation, 2 (0.4%) corresponded25.0
histologically to mucinous carcinoma, while 1 case
(0.2%) was diagnosed as hepatoid adenocarcinoma.
Out of 475, 326 (68.6%) were poorly differentiated
(signet ring adenocarcinoma or diffuse type) while 149 0
(31.4%) were well to moderately differentiated (intestinal
type adenocarcinomas). The p-value was statistically
significant (0.002). The decade wise breakup is shown
in Tables 2 and 3.
A total of 489 cases of skin carcinoma were diagnosed.
Of these, 288 (58.9%) were diagnosed in males and 201
(41.1%) in females. M:F ratio was 1.43:1.0. The histologic
types included squamous cell carcinoma comprising
253 cases (51.7%), basal cell carcinoma comprising
152 cases (31.1%), malignant melanoma comprising 55
cases (11.2%) and cloacogenic carcinoma comprising 7
cases (1.4%). Other histologic types included adnexal
carcinomas NOS comprising 9 cases (1.8%), sebaceous
carcinoma comprising 6 cases (1.3%), 1 case each of
trichilemmal carcinoma and kaposi sarcoma (0.2%) and 2
cases of merkel cell carcinoma (0.4%). In 4 cases (0.8%),
exact histologic type or origin could not be determined.
The decade wise breakup is shown in Tables 2 and 3.
A total of 380 cases of lung cancer were diagnosed.
Of these, 303 (79.7%) were diagnosed in males and 77
(20.3%) in females. M:F ratio was 3.93:1.0. The p-value
was statistically significant (<0.0001). Out of 380 cases,
198 (52.1%) involved the right lung and 130 (34.2%)
involved in left lung. In 52 cases (13.7%), laterality was
not known. The breakup of the histologic types is shown
in Table 8.
A total of 356 malignant CNS neoplasms were
diagnosed. Of these, 239 (67.1%) were diagnosed in
males while 117 (32.9%) were diagnosed in females. M:F
ratio was 2.04:1.0. The value was statistically significant
(p-value: <0.0001). The breakup of the histologic types
is shown in Table 9.
A total of 325 cases of urinary bladder carcinoma
were diagnosed during the study period. Of these,
245 (75.4%) were diagnosed in males and 80 (24.6%)
in females. M:F ratio was 3.06:1.0. This value was

6.3

56.3

31.3

Newly diagnosed without treatment
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Table 8. Frequency of Various Histologic Types of Lung Carcinoma, Malignant Salivary Gland Tumors and
Thyroid Gland Tumors in Males and Females
Primary lung carcinoma in males and females (n=380)
Histologic Type
Squamous cell
carcinoma

Male (n=303)
Number
124

(%)
40.90%

Malignant salivary gland tumors (n=88)

Female (n=77)
Number
20

(%)
26%

Histologic type
Mucoepidermoid
carcinoma

Male (n=55)
Number
25

(%)
45.50%

Thyroid carcinoma (n=137)

Female (n=33)
Number
14

(%)

Histologic
type

Male (n=46)

Female (n=91)

Number

(%)

Number

(%)

42.40%

Papillary
carcinoma

27

58.70%

52

57.10%

7

15.20%

10

11.00%

Adenocarcinoma

117

38.60%

42

54.50%

Adenoid cystic
carcinoma

11

20.00%

10

30.30%

Papillary
carcinoma,
follicular
variant

Small cell
carcinoma

46

15.20%

9

11.70%

Polymorphous
low grade
carcinoma

6

10.90%

3

9.10%

Follicular
carcinoma

6

13.00%

11

12.10%

Large cell neuroendocrine carcinoma

4

1.30%

1

1.30%

Carcinoma ex
pleomorphic
adenoma

5

9.10%

2

6.10%

Anaplastic
carcinoma

3

6.50%

7

7.70%

Adenosquamous
carcinoma

4

1.30%

2

2.60%

Acinic cell
carcinoma

2

3.60%

1

3.00%

Medullary
carcinoma

3

6.50%

6

6.60%

Sarcomatoid
carcinoma

2

0.70%

1

1.30%

Myoepithelial
carcinoma

2

3.60%

2

6.10%

Insular carcinoma

--

--

3

3.30%

Undifferentiated
large cell
carcinoma

1

0.30%

--

--

Malignant mixed
tumor

1

1.80%

1

3.00%

Hurthle cell
carcinoma

--

--

2

2.20%

Non-small cell
carcinoma, NOS

4

1.30%

1

1. 3%

Poorly
differentiated
carcinoma

1

1.80%

--

--

Bronchoalveolar
carcinoma

1

0.30%

1

1. 3%

Carcinosarcoma

2

3.60%

--

--

statistically significant (p-value: <0.0001). All 325 cases
corresponded histologically to urothelial carcinomas. Of
these, appreciable squamous differentiation was seen in 27
(8.3%) and glandular differentiation in 22 (6.8%) cases.
Sarcomatoid areas were seen in 9 cases (2.8%). Out of
325, 218 (67.1%) were high grade urothelial carcinomas.
The p-value was statistically significant (<0.0001). 90
(27.7%) were low grade, while 17 (5.2%) corresponded to
papillary urothelial neoplasm of low malignant potential.
Of the 218 high grade tumors, 142 (65.1%) were detrusor
muscle invasive (statistically in significant, p-value:
0.2018), 30 (13.8%) were non muscle invasive while no
detrusor muscle was present in the specimen to assess
invasion in 46 cases (21.1%).
A total of 270 cases of carcinoma of larynx and
vocal cord were diagnosed during the study period. Of
these, 165 (61.1%) were diagnosed in males and 105
(38.9%) in females. M:F ratio was 1.57:1.0. The value
was statistically not significant (p-value: 0.063). Of the
270 cases, 260 (96.3%) corresponded histologically to
conventional squamous cell carcinoma, while 10 (3.7%)
were reported as spindle cell carcinoma (sarcomatoid
carcinoma). The p-value was statistically significant
(<0.0001).
A total of 248 cases of malignant ovarian tumors were
diagnosed during the study period. The right ovary was
involved in 45 cases (18.1%) and the left ovary in 52 cases
(21%). Bilateral involvement was seen in 59 cases (23.8%).
Laterality was not known in 92 cases (37.1%). The decade
wise breakup is shown in Table 2 while the breakup of
histologic types is shown in Table 5. A total of 179 cases
of endometrial carcinoma were diagnosed during the study
period. Of these, 97 (54.2%) were well differentiated,
75 (41.9%) were moderately differentiated and 7 (3.9%)
were poorly differentiated. Histologically, 3 out of 179
(1.7%) corresponded to papillary serous carcinoma and
1 (0.6%) to clear cell carcinoma. In addition to these 179,

another 8 (4.3%) endometrial malignant tumors were
diagnosed which included 3 cases of malignant mixed
mullerian tumors, 3 cases of endometrial stromal sarcoma
and 1 case each of adenosarcoma and leiomyosarcoma.
A total of 140 cases of carcinoma cervix were diagnosed
during the study period. The overwhelming majority 137
(97.8%) were histologically consistent with squamous
cell carcinoma. The p-value was statistically significant
(<0.0001). Remaining 3 cases (2.2%) were histologically
consistent with cervical adenocarcinoma. The decade wise
breakup of malignant endometrial and cervical tumors is
given in Table 2.
Out of a total of 137 thyroid carcinomas diagnosed
during the study period, 46 (33.6%) were diagnosed
in males and 91 (66.4%) in females. This value was
statistically not significant (p-value: 0.0722). F:M ratio
was 1.97:1.0. The breakup of histologic types is shown
in Table 8.
Out of a total of 123 renal cancers diagnosed during
the study period, 80 (65%) were diagnosed in males
and 43 (35%) in females. The value was statistically not
significant (p-value: 0.1488). M:F ratio was 1.86:1.0.
56 (45.5%) were located in the right and 53 (43.9%) in
the left kidney. In 2 cases (1.6%), the tumors involved
both kidneys. In 12 cases (10%), laterality was not
known. Histologically, 100 out of 123 cases (81.3%)
were consistent with clear cell renal cell carcinoma. This
value was statistically significant (p-value: <0.0001).
Of the remaining 23 cases, 11 (8.9%) were consistent
with sarcomatoid carcinoma, 8 (6.5%) with papillary
carcinoma, while 2 cases each (1.6%) were consistent
with chromophobe renal cell carcinoma and squamous
cell carcinoma. The decade wise breakup is shown in
Tables 2 and 3.
Out of 102 malignant testicular tumors, 48 (47.1%)
were located in the right testis, 29 (28.4%) in the left while
1 case (1.0%) involved both. In 24 cases (23.5%), laterality
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Table 9. Histologic Types of Malignant CNS Neoplasms
in Both Males and Females (n=356)
Histologic type
Diffuse Astrocytoma, Grade II
Anaplastic Astrocytoma, Grade
III
Glioblastoma Multiforme, Grade
IV
Oligodendroglioma, Grade II
Anaplastic oligodendroglioma,
Grade III
Ependymoma, Grade II
Anaplastic Ependymoma, Grade
III
Atypical Meningioma, Grade II
Anaplastic Meningioma, Grade
III
Medulloblastoma, Grade IV
CNS PNET, Grade IV *
Gliosarcoma, Grade IV
Glioblastoma with
oligodendroglioma Component
(GBMO), Grade IV
Anaplastic Oligoastrocytoma,
Grade III
Oligoastrocytoma, Grade II
Pleomorphic Xanthoastrocytoma,
Grade II
Central Neurocytoma, Grade II
Atypical Choroid Plexus
Papilloma, Grade II
Pineocytoma, Grade II
Ganglioglioma, Grade II
AT/RT, Grade IV **
Hemangioblastoma, Grade II
Anaplastic Hemangiopericytoma,
Grade III

4

Percentage
(%)
1.1%

3

0.8%

76

21.3%

54

15.2%

72

20.2%

19

5.3%%

16

4.5%

26

7.3%

3

0.8%

31
5
6

8.7%
1.4%
1.7%

15

4.2%

8

2.2%

1

0.3%

6

1.7%

3

0.8%

1

0.3%

1
1
2
1

0.3%
0.3%
0.6%
0.3%

2

0.6%

Total No.

* Primitive Neuroectodermal Tumor; ** Atypical Teratoid and Rhabdoid
Tumor

was not known. Seminoma and malignant mixed germ cell
tumors were the commonest histologic types comprising
44 (43.1%) and 35 (34.3%) cases respectively. Other types
including Yolk Sac tumor (14 cases, 13.7%), immature
teratoma (6 cases, 5.9%), embryonal carcinoma (2 cases,
1.9%) and malignant sertoli cell tumor (1 case, 1%). The
decade wise breakup is shown in Table 3.
A total of 237 cases of prostatic adenocarcinoma were
diagnosed in the study period. Average Gleason grade
(score) was 6 in 41% and 7 in 39%. Average tumor volume
was 60 to 65%. Perineural invasion was present in 110
cases (46.4%). Out of 237 cases, 9 patients (3.8%) were
under 50 years of age, 43 (18.2%) were between 51 and
60, 105 (44.3%) were between 61 and 70 and 80 (33.7%)
were above 70 years of age.
Out of a total of 119 cases of Ewing sarcoma
diagnosed, 63 (52.9%) were diagnosed in males and 56
(47.1%) in females. M:F ratio was 1.12:1.0. Of the 119
cases, 52 (43.7%) were bone based while 63 (52.9%)

1068

Asian Pacific Journal of Cancer Prevention, Vol 17, 2016

were soft tissue based. In 4 cases (3.4%) location was
not known. The decade wise breakup is given in Tables
2 and 3.
As many as 75 (72.1%) out of 104 Gall bladder
carcinomas were diagnosed in females while 29 (27.9%)
were diagnosed in males. This value was statistically
significant (p-value: <0.0001). In 101 cases (97.1%),
the tumor invaded full thickness of the wall and invaded
the peri-muscular connective tissue. This value was
statistically significant (p-value: <0.0001). In 35 cases
(33.6%), the tumor perforated the serosa (visceral
peritoneum) and directly invaded the liver or another
organ. Cystic duct resection margin was positive in 21
cases (20.2%). In 3 cases (2.9%), specimen was received
in multiple pieces and it was not histologically possible to
determine the extent of tumor invasion. The decade wise
breakup is given in Tables 2 and 3.
A total of 88 malignant salivary gland tumors were
diagnosed. Of these, 55 (62.5%) occurred in males and
33 (37.5%) in females. The p-value was statistically not
significant (0.0838). The M:F ratio was 1.66:1.0. The
decade wise breakup is given in Tables 2 and 3 while
histologic types are shown in Table 8.
Of the 86 cases of osteosarcoma, 52 (60.5%) were
diagnosed in males and 34 (39.5%) in females. M:F ratio
was 1.53:1.0. Femur and tibia were the commonest sites
comprising 25 (29.1%) and 24 (27.9%) cases respectively.
Other bones involved were humerus (7 cases, 8.1%),
radius (5 cases, 5.8%), ileum (4 cases, 4.6%), fibula (4
cases, 4.6%), rib (3 cases, 3.5%), jaw (2 cases, 2.3%),
ulna (2 cases, 2.3%) and foot (2 cases, 2.3%). In 8 cases
(9.3%), exact location was not known. The decade wise
breakup is given in Tables 2 and 3.
Of the 82 cases of hepatocellular carcinoma seen
during the study period, 47 (57.3%) were diagnosed in
males and 35 (42.7%) in females. M:F ratio was 1.3:1.0.
All cases were diagnosed on core biopsies. As many as
80 (97.6%) were histologically well differentiated. This
value was statistically significant (p-value: <0.0001). The
decade wise breakup is given in Tables 2 and 3.

Discussion
Carcinoma of the oral cavity, lymphoma (Non Hodgkin
and Hodgkin combined) and esophageal carcinoma
were among the top five malignancies in both males and
females. Breast cancer was the commonest cancer in
females (32% of all malignancies in females) and it was
overall the single most common type of cancer reported.
In males, colorectal and gastric carcinomas rounded off
the top five. In females, ovarian carcinoma completed the
top five while colorectal carcinoma, fifth overall in both
sexes combined, was at number six. Lung cancer, among
the top three cancers in most international studies was
eighth overall in our series, sixth in males and fifteenth in
females. The lower incidence in females can be attributed
to smoking habits (women in Pakistan smoke much less
compared to women in other parts of the world). Gastric
carcinoma, fourth in males was at seventh place overall
due to its lower (tenth) place in females. Skin cancer was
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very common occupying sixth place overall and seventh
place in both sexes. Malignant tumors of the CNS occupied
ninth place overall in our series, and ninth and eleventh
place in males and females respectively. Carcinoma of
the urinary bladder was at tenth place overall, eighth
in males and fourteenth in females. Carcinomas of
endometrium and cervix occupied the eighth and ninth
places in females. In males, prostatic carcinoma, among
the top three malignancies in most series was at number
ten. Cancer of larynx and vocal cord occupied eleventh
place overall, eleventh in males and twelfth in females.
A comparison with incidence rates of different cancers
around the world is at this point warranted. Across Asia,
the incidence rates vary greatly and there are significant
(three fold) differences in both sexes.(Shin et al., 2010) In
Thailand, lung cancer was the commonest cancer in both
males and females but in a particular region of Thailand,
liver cancer was the commonest. In females, breast and
cervical cancer were the most common while oral and
pharyngeal cancers were also extremely common in both
sexes. This variability in the incidence of various types of
cancers even within different regions of the same country
results from different risk factors prevalent in different
regions to which the populations of particular areas are
exposed.(Sriplung et al., 2005) In Thailand, colorectal and
breast cancers showed a statistically significant increasing
trend in the 1990s while incidence rates of other cancers
remained sTable.( Sriplung et al., 2005) In India, lung,
esophagus, stomach, oral and pharyngeal cancers were
the commonest cancer types in males while cancers
of cervix and breast followed by oral cavity, stomach
and esophagus were the predominant cancer types in
females.(Murthy et al., 2008) A report using data from
India’s National Cancer Registry Program showed that
the incidence of various types of cancers in India was
increasing in both sexes and that increase in population
size, increase in the number of elderly people, urbanization
etc. were responsible for this increasing cancer burden. It
noted that the existing diagnostic and treatment facilities
were inadequate to tackle the present cancer load and
recommended that these facilities be urgently strengthened
and increased to handle the cancer load which is expected
to increase consistently till 2026.(D’Souza et al., 2013) It
is unfortunate that in Pakistan, there is not even a regional
cancer registry, what to say of a national one. Our situation
is identical to India in terms of rising cancer burden and
grossly inadequate diagnostic /treatment facilities but
tragically, we do not have the data to determine the exact
magnitude of an undeniably grim situation. Past and recent
attempts to develop regional cancer registries were not
very successful.
Data from two population based registries in Ibadan
and Abuja regions in Nigeria showed that breast and
cervical cancers were the commonest cancers in females
while carcinoma of the prostate was the commonest cancer
in males. About 66% cancers were seen in females.(JedyAgba et al., 2012) In Malawi, almost 60% cancers were
seen in females. Cancer of cervix was the commonest
followed by kaposi sarcoma, cancers of esophagus, breast
and non-Hodgkin lymphoma. In males, Kaposi sarcoma
was the commonest followed by cancer of esophagus,

non-Hodgkin lymphoma and cancers of prostate and
urinary bladder. Cervical cancer accounted for over 45%
of all cancers in females, while Kaposi sarcoma accounted
for almost 51% of all cancers in males. Even in females,
Kaposi sarcoma comprised over 21% of all malignancies.
Surprisingly, the incidence of breast carcinoma was very
low in Malawi (4.6%), a figure much lower than anywhere
else in the world.(Msyamboza et al., 2012)
Unlike other studies from Asia and Africa, where
carcinoma of cervix was among the top most malignancies,
it was the ninth most common cancer in females in our
series accounting for 2.7% of all cancers in females. This
low incidence of carcinoma cervix may reflect low sexual
promiscuity in Pakistani women.
In Europe, data from a population based cancer registry
in Cyprus- a Mediterranean country with a unique cultural
and environmental setting- prostate, lung, colorectal and
bladder cancers were the commonest in males, while
breast, colorectal, uterine and thyroid cancers were the
commonest cancers in females. This study found that the
overall cancer incidence in Cyprus was lower compared
to the other countries in the region.(Cooter et al., 2015) A
study by the Italian network of cancer registries showed
that cancer incidence was increasing in both sexes.
However, mortality from cancer was decreasing. Prostate
and lung cancer were the commonest cancers in Italian
males while breast cancer accounted for about one-fourth
of all cancers in females.(AIRT Working Group, 2006)
In general, the incidence of cancers is increasing
worldwide, although incidence of specific types has
stabilized in the developed countries. Mortality from
cancer is decreasing in the developed world. This is unlike
the developing world where both cancer incidence and
cancer mortality are increasing, while the infrastructure
to fight cancer is grossly inadequate.
A recent study from Germany(Bahr et al., 2015)
showed that the number of new cancer cases in Germany
will go on increasing at least up to 2020 and that the
number of hospital days and sickness costs will increase.
In North America, data from a study on epidemiology
of cancer in United States(Cresanta, 1992) demonstrated
that just four cancers (breast, lung, prostate and colorectal)
accounted for 56% of all cancer related mortality. The
study highlighted genetic and environmental factors
important in specific types of cancer for example cigarette
smoking and tobacco abuse (in cancer of lung, oral cavity,
larynx, esophagus, pancreas, urinary bladder, kidney),
young black women (breast), black men (lung & prostate),
young whites with excessive sun exposure (malignant
melanoma), and the elderly (colorectal cancer). US
data focusing on cancer trends between 1975 and 2000
showed that incidence of all cancers in the US increased
from the mid-seventies upto 1992, rates then decreased
between 1992 and 1995 and finally stabilized between
1995 and 2000. Similarly, mortality rates from all cancer
sites declined from 1994 to 1998 and then stabilized from
1998 through 2000.(Weir et al., 2003) Yearly US cancer
statistics compiled by the American Cancer Society
based on the most recent data on cancer incidence and
mortality demonstrated that incidence and mortality rates
from all cancer sites continued to decrease from 2000
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onwards in males. However, incidence rates continued
to increase by about 0.3% per year in females from 1995
through 2003. Mortality rates continued to decrease for
the three commonest cancers in males (lung, colorectum
and prostate) as well as for the commonest cancers in
females (breast and colorectum). In 2004, cancer death
rates in males and females fell by 18.4 % and 10.5%
respectively compared to the nineties. Cancer incidence
rates in females began to fall around 2000 by about 0.6%
per year through 2005. Cancer mortality rates in males
declined by 19.2% between 1990 and 2005 and about
80% of the decrease was due to decreased mortality from
lung, prostate and colorectal cancers. Similarly, mortality
rates in females declined by 11.4 % and about 60 % of
the total decrease was due to decreased mortality from
breast and colorectal cancers. The decline in cancer
mortality rates in the United States over a 16 year period
resulted in the avoidance of around 767,000 deaths. This
figure emphasizes the importance of disseminating our
current knowledge of cancer in all segments of population
and the importance of supporting new advancements in
cancer prevention techniques as well as early detection
and treatment of cancer. (Jemal et al., 2004; Jemal et al.,
2006; Jemal et al., 2007; Jemal et al., 2008; Jemal et al.,
2009; Jemal et al., 2010)
As shown in Table 4, a total of 768 out of 10,000
malignant tumors (7.7%) were diagnosed in patients upto
20 years of age. The most frequent in this age group were
Non-Hodgkin Lymphoma (123), Hodgkin Lymphoma
(109), Ewing Sarcoma (87), malignant CNS tumors (73)
and Osteosarcoma (63 cases). Other tumors diagnosed
frequently in young patients included rhabdomyosarcoma
(37 cases), ovarian malignant tumors (30), Synovial
sarcoma (26), testicular malignant tumors (25), Wilm’s
tumor (22), neuroblastoma (20) and retinoblastoma (19
cases). It is important to remember that only solid tumors
were included in our study and leukemias (extremely
common in the young) were not included. In the US,
solid tumors of the CNS were the commonest malignant
tumors in children up to age of 14 years.(Cresanta, 1992)
In Brazil, the commonest malignant tumors in children,
based on fourteen population based cancer registries,
were lymphomas and CNS tumors.(de Camargo et al.,
2010) However, in both US and Brazil, leukemia was
the commonest malignancy in children and adolescents.
(Cresanta, 1992; de Camargo et al., 2010) In Shanghai,
China, based on data from the population based Shanghai
Cancer Registry, the five commonest solid malignant
tumors in children up to the age of 14 years were malignant
CNS tumors, lymphomas, malignant germ cell tumors,
neuroblastoma and soft tissue sarcoma. The incidence rate
for malignant tumors was the highest in the first five years
of life.(Bao et al., 2013) In Italy, data AIRTUM showed
that cancer incidence was greater in the 0-14 than in the
15-19 year age group. Leukemias were the commonest
malignances. Among solid tumors, Non Hodgkin
and Hodgkin lymphoma, malignant CNS tumors and
neuroblastomas were the commonest. Cancer incidence
rates were decreasing in the 0-14 year age group, while
they were still increasing in the 15-19 year age group.
However, cancer mortality showed a persistent decline in
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both age groups.(AIRTUM Working Group, 2013) These
studies show that, similar to our study, malignant CNS
tumors are common in children and adolescents. Data
on childhood CNS tumors from 13 Eastern and Southern
European Cancer registries showed that astrocytomas
constituted the most common malignant CNS tumors in
the age groups 0-14 years (30%) followed by embryonal
tumors (26%).(Papathoma et al., 2015)
As seen in Table 4, malignant tumors were most
common in the 31 to 70 year age group reaching a peak
in the 41 to 60 year age group.
Breast cancer is the commonest type of cancer and
the commonest cause of death from cancer in women
worldwide. Its incidence is highest in North America and
Europe and low in Asia and Africa.(Parkin et al., 2001)
However, as seen in Tables 1 and 2, this is not the case
in Pakistan. It was the most common cancer in women
comprising 32% of all cancers diagnosed in women. It
was slightly more common in the left breast i.e. 47.7%
compared to 41.5% in the right breast. As shown in
Table 5, over 72% cases were diagnosed in the age range
31 to 60 years. Invasive Ductal Carcinoma, NOS was
the commonest histologic type comprising 86% of all
cases (Table 5). This figure was higher than the figure of
approximately 75% reported in some studies.(Berg and
Hunter, 1995)
In the United States, the incidence and death rate from
breast cancer are constantly declining.(Jemal et al., 2009;
Jemal et al., 2010) In our neighboring India, breast cancer
has replaced cancer of cervix as the commonest in females
especially in urban areas where it comprises 30 to 40%
of all cancers in women.(Nanda Kumar et al., 2010) This
change from cervix to breast occurred in just over a decade
(1990 to 2003). The incidence rate of cancer of cervix is
decreasing while that of breast cancer is increasing.(Takiar
and Srivastav, 2008)
The high incidence of oral cancer in both sexes is
related to the widespread ingestion of paan (betal quid),
chalia, naswaar; cigarette, cigar and hooka smoking;
poor oral hygiene etc. As shown in Tables 2 and 3, oral
cancer was commonest in the fifth and sixth decades of
life. The inner cheek (buccal) mucosa was the commonest
site in the oral cavity followed by the tongue. (Table
6). Mouth and tongue cancer is very common in the
subcontinent, where many of the major risk factors such
as cigarette or bidi smoking, betal quid chewing, tobacco
chewing etc are rampant. It is no wonder that the highest
incidence rates of oral cancer in females are found in
the Indian subcontinent.(Snkaranarayanm et al., 1998)
In India, studies have shown regional differences in the
incidence rates of oral cancers in both males and females
according to data from registries in different regions of
the country.(Yeole, 2007) One study showed that buccal
mucosa was the commonest site of oral squamous cell
carcinoma comprising 63.7% followed by retro molar
area comprising 15%. This study also concluded that
the incidence rates of oral cancer vary widely according
to geographic location. However, it emphasized that
even within one location, other factors such as age, sex,
site, habit etc cause further variation in incidence rates.
(Sharma et al., 2010) The US National Cancer Institute’s
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SEER data showed that incidence rate as well as five
year survival rate from oral cancer had remained constant
inspite of advances in surgery and radiation. The study
emphasized that early detection of localized lesions with
appropriate treatment and aggressive counseling of the
public to prevent use and give up smoking and alcohol
were extremely important in decreasing the morality rates
from oral cancer.(Silverman, 2001)
Israel is another country with very high incidence
rates of oral cancer. Data from the Israel National Cancer
Registry showed that squamous cell carcinoma in males
was extremely common above age 55 years.(Zini et al.,
2010) A large population of fair skinned people and
high level of sun exposure have resulted in the lip being
the commonest site for oral cancer comprising 36.8%.
( Zini et al., 2010) In Israeli Arabs, most cases of oral
cancer occurred in males (high level of smoking), mean
age was 54.4 years, oropharynx was the commonest site
(28.3%), while squamous cell carcinoma was the most
common histologic type.( Zini et al., 2012) All the above
studies on oral cancer from around the world demonstrate
geographical and regional variations in incidence rates,
and also show considerable variation in the commonest
exact site depending on multiple factors including habit,
tobacco and alcohol , exposure to sun etc.
Lymphomas were among the three commonest
malignancies in both males and females. They were
more common in males and over 75% were non Hodgkin
lymphomas (NHL). Nodal were more common (51.2%)
than extra nodal NHLs (48.8%). Nodal NHLs in both
sexes were most common in the fourth to seventh
decades, whereas extra nodal NHLs were more evenly
distributed from the second to seventh decades of life. The
gastrointestinal tract (stomach, small intestine, and colon)
was the commonest site of extranodal NHLs followed by
bone. Diffuse Large B Cell Lymphoma (DLBCL) was the
commonest histologic type of NHL, comprising 48.5% of
nodal and almost 68% of extra nodal NHLS.
Hodgkin lymphoma (HL) was most common in
the first to third decades of life in males. However, it
occurred at a somewhat older age in females with most
cases in the second to fifth decades. Mixed Cellularity and
Nodular Sclerosis histologic subtypes were almost equally
common. Italian cancer figures reported that incidence
of HL was increasing in women although mortality from
HL decreased significantly in both males and females.
(AIRT Working Group, 2006) In the United States, acute
lymphoblastic leukemia was the commonest malignancy
in children up to the age of 14 years.(Cresanta, 1992) In
our study, precursor B and T lymphoblastic lymphomas /
acute lymphoblastic leukemias accounted for almost 14 %
of all NHLs (Table 7). A study from Jordan showed similar
results with NHLs comprising over 78.4 % and extra nodal
lymphomas 30.5% of all lymphomas.(Haddadin, 2005)
In our series, NHL comprised over 75% and extranodal
lymphomas 30.5% (identical to the figures from Jordan)
of all lymphomas. There is a strikingly evident but
unexplained male predominance in many lymphoma
subtypes in all age groups and autoimmune diseases
are associated with increased risk for development of
lymphomas especially in females.(Roman and Smith,

2011) This marked propensity of NHLs for males in both
children and adults was also noted in two recent studies
from United Kingdom, which also demonstrated that
males were usually diagnosed at younger ages compared
to females. However, no survival difference was detected
between males and females.(Smith et al., 2011; Smith et
al., 2015)
Esophageal carcinoma was the second commonest
malignancy in women. As many as 53.2% esophageal
carcinomas in our series were diagnosed in women. In
65% cases, the tumor was located in the lower third of
the esophagus. Over 97% were squamous cell carcinomas
on histologic examination. Over 66% were diagnosed in
the fifth, sixth and seventh decades of life (Tables 2 and
3). These findings were similar to our earlier findings.
(Ahmad et al., 2013) Over 31% cases were received from
Baluchistan province along Pakistan’s borders with Iran,
Afghanistan and China. The above mentioned geographic
region has well documented high rates for esophageal
cancers in both males and females.(Curado et al., 2013)
Colorectal carcinoma was much more common
in males (64.5%). Over 75% were located in the left
colon especially in the sigmoid and rectum. All cases
corresponded histologically to adenocarcinomas.
Colorectal carcinoma was most commonly diagnosed in
the fourth to seventh decades of life. Our earlier study
showed similar findings with almost 63% occurring in
males and over 80% in the left colon.(Ahmad et al., 2013)
Gastric Carcinoma was also much more common
in males. Almost 71% occurred in males. Almost
37% were located in the distal stomach. All cases
were adenocarcinomas and almost 69% were poorly
differentiated signet ring adenocarcinomas on histologic
examination. In our earlier study, over 67% occurred in
males, 62% were located in the distal stomach and over
74% were poorly differentiated signet ring carcinomas.
(Ahmad et al., 2013) Helicobacter pylori infection is very
common in Pakistan and it is among the high prevalence
countries for H pylori infection.(Khan et al., 2013) This is
probably an important etiologic factor contributing to the
high incidence rates of gastric cancer in Pakistan.
Although we do not have exact figures, the incidence
of cancers of esophagus, stomach and colon are increasing
in Pakistan. Esophageal cancer is extremely common
worldwide and has a high mortality rate.(Herszenyi
and Tulassay, 2010) Incidence and mortality rates have
recently shown a reducing trend in some parts of the world.
(Xie et al., 2012) However, in Asia, the incidence and
mortality rates remain high.(Lin et al., 2013; Bafandeh
et al., 2006) The incidence and mortality rates associated
with gastric cancer remain very high in developing
countries.(Miwa et al., 2002) However, these rates have
decreased significantly in many developed countries.
(Crew and Neugut, 2006) Gastric cancer remains very
common in East Asia, Eastern Europe and in Central and
South America.(Herszenyi and Tulassay, 2010) In both
United States and Italy, incidence and death rates for
gastric and colorectal cancers have shown a significant
decrease in both sexes.(AIRT Working Group, 2006;
Jemal et al., 2010) However, colorectal cancer remains
one of the commonest cancers worldwide with the highest
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incidence rates in developed countries in North America,
Europe, Australia and New Zeeland and remains a leading
cause of death, with obesity and physical inactivity as
important contributing factors. Although its incidence is
considered to be low in Asia, Africa and South America
(poor or developing countries),(center et al., 2009)
this is not our experience. It exacts a heavy toll in both
morbidity and mortality in Pakistan. Developed Asian
countries like Hong Kong, continue to show increased
incidence rates for colorectal cancer(Xie et al., 2012)
and developing countries like Iran and Thailand also
demonstrate increased incidence rates in both males and
females.(Khuhaprema and Srivatanakul, 2008; Abdifard
et al., 2013)
Skin cancer was common in both sexes. Almost
59% were diagnosed in males. The large majority were
diagnosed from the fourth decade onwards (Tables 2
and 3). The three commonest histologic types were
squamous cell carcinoma (51.7%), basal cell carcinoma
(31.1%) and malignant melanoma (11.2%). This is in
contrast to western data which indicate that BCC is the
commonest histologic type (approximately 70%) followed
by SCC.(52,53) In Pakistan, although there is severe sun
exposure, the large majority of people are dark-skinned.
The incidence of these cancers is directly related to the
amount of sun exposure and the lack of melanin pigment
in the skin.(Casson, 1980, Crowson, 2006) However, the
low incidence of malignant melanoma, as compared to
the west where it is among the ten commonest malignant
tumors in both males and females(Jemal et al., 2010) is
in accordance with the well-known fact that these tumors
mainly occur with excessive sun exposure in fair skinned
people who have very little melanin pigment in their skin.
(Beral et al., 1983)
Lung cancer was at number six among males.
However, it was much less frequent in females (Tables 2
and 3), most likely due to the fact that cigarette smoking
is much less common in Pakistani women compared
to the west. Pakistani women are more likely to smoke
huqqa, a tobacco preparation. Huqqa smoking is more
prevalent in women living in rural areas compared to
those living in cities. Even among males, lung cancer
was much less common compared to the West where it
remains the commonest cancer in both sexes. In the US,
at least among males, its incidence rate and mortality are
decreasing.(Jemal et al., 2010) Italian figures also show
a decrease in mortality rate from lung cancer in males.
However in Italian women, the incidence of lung cancer
is increasing.(AIRT Working Group) In US women, the
mortality rates from lung cancer were increasing in those
states where prevalence of smoking was higher.(Jemal et
al., 2008) Lung cancer remains a deadly and devastating
disease worldwide and five year survival rates remain
under 20%.(Williams and Sandler, 2001) In our series,
the majority of cases in both males and females occurred
in the fifth, sixth and seventh decades of life (Tables 2
and 3). It was much more common in males (79.7%). The
right lung was involved more commonly (51.2% cases).
Among histologic types, squamous cell carcinoma and
adenocarcinoma were almost equally represented, while
small cell carcinoma comprised just over 15% (Table
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8). A recent Study from Poland showed that lung cancer
accounted for almost half of all cancer related deaths in
people above 65 years of age.(Radziszewska et al., 2015)
An interesting study from Guangzhou, China showed
that apart from the major risk factors like smoking, air
pollution and certain occupational hazards, other less
well documented risk factors such as degree of indoor air
pollution, general conditions in homes, cooking practices
and cooking environment, size of the kitchen etc. were
important especially in relation to the development of
lung cancer in nonsmoking females. This study also made
the interesting observation that consumption of fresh
vegeTables was a protective factor for lung cancer in both
genders.(Du et al., 1996)
Malignant tumors of larynx and vocal cord were also
common. Cancer of larynx was much more common
in males (61%). The large majority of cases in both
sexes were diagnosed in the fifth, sixth and seventh
decades of life (Tables 2 and 3). Over 96% corresponded
histologically to squamous cell carcinoma. According to
Western data, cancer of larynx accounts for 2.2% of all
cancers in males and 0.4% in females, most cases are
diagnosed in the fifth decade of life and beyond and almost
96% patients are males.(Rafferty et al., 2001) In our study,
compared to western data, the tumor was more common in
females accounting for 2.7% of all cancers in both genders,
3.4% of all cancers in males and just over 2% of all cancers
in females (Tables 1 to 3). Cigarette smoking is a major
risk factor for cancer of larynx.(Muscat and Wynder, 1992)
However, tobacco abuse in other forms is also a major risk
factor(Cresanta, 1992) and the smoking of huqqa (a form
of tobacco) especially in rural areas probably accounts for
increased incidence rate of laryngeal cancer in Pakistani
women compared to the west.
Ovarian cancer was among the five commonest cancers
in females. Papillary serous carcinoma and endometrioid
carcinoma were the commonest histologic types. Ovarian
malignant tumors were evenly distributed in the third to
seventh decades of life with a peak in the fifth decade.
Almost 12% occurred in patients 20 years or younger
(Table 2). The incidence of ovarian carcinoma has
remained relatively constant around the world. However,
recent Italian figures showed a decrease in incidence.
(AIRT Working Group, 2006) According to US Cancer
Statistics, 2010,(Jemal et al., 2010) ovarian cancer was
the ninth commonest cancer in women accounting for
3% of all cancers in women and was the fifth commonest
cause for death from cancer in women accounting for 5%
of all deaths. In our series, ovarian cancer accounted for
4.8% of all cancers in women (Table 2). Ovarian cancer
is responsible for the greatest number of deaths resulting
from malignant tumors of the female genital tract.
(Cannistra, 2004) Since ovarian cancer has a high casefatality ratio (due mostly to late diagnosis), recent studies
have attempted to build risk prediction models which
can help identify women at increased risk. Such women
can benefit from targeted prevention measures such as
screening or chemo preventive drugs.(Li et al., 2015)
Malignant CNS neoplasms were surprisingly common
accounting for almost 5% of all malignant tumors in males
(Table 3) and over 3.5% overall (Table 1). Over 67% were
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diagnosed in males. Glioblastoma Multiforme (GBM) and
grade II and III oligodendrogliomas were the commonest
CNS malignancies comprising almost 57% of all cases.
Medulloblastoma was the commonest malignant CNS
neoplasm in children. The majority of malignant CNS
tumors were diagnosed in the third to sixth decades of
life in males and in the second to fifth decades in females.
However, over 18% in males and almost 25% in females
occurred in patients younger than 20 years of age (Tables
2 and 3). In the United States, diffuse astrocytomas were
the most common primary intracranial tumors comprising
almost 60% and approximately 8% of these were GBMs.
Oligodendrogliomas, grades II and III accounted for only
4% of primary intracranial tumors.(CBTRUS, 2008) In
our series, grade II and III oligodendrogliomas comprised
over 35% of all primary brain tumors while grade II , III
and IV astrocytomas comprised just over 23% of which
the large majority were GBMs (Table 9). However, in a
previous study performed in our department, the number
of astrocytic and oligodendroglial neoplasms was almost
equal.(Zubair et al., 2011)
Urinary bladder cancer was very common in males.
It was the eighth commonest malignancy in males and
fourteenth commonest in females. Over 75% cases
were diagnosed in males. All cases were histologically
consistent with urothelial carcinoma. Over 67% were
high grade cancers of which over 65% of which were
detrusor muscle invasive. This figure could be higher
since in over 21% cases, no deep muscle was present in
the biopsy to assess muscle invasion. International studies
show that bladder cancer is the seventh commonest cancer
worldwide accounting for about 3.2% of all cancers and
is more than three times more common in males than
females with a worldwide M:F ratio of 3.5:1.(Parkin et
al., 1994; Ferlay et al., 2001) According to US Cancer
Statistics 2010,(Jemal et al., 2010) bladder cancer was the
fourth commonest cancer in males accounting for 7% of all
cancers However, mortality wise it was ninth accounting
for 3% for all cancer deaths in males. According to Italian
Cancer Figures 2006,(AIRT Working Group, 2006)
incidence and mortality rates of bladder cancer decreased
in males. In both males and females, bladder cancer is
most prevalent in North America, Western Europe and
Australia.(Pisani et al., 2002; Parkin et al., 2003) Although
considered to be much more common in developed
compared to developing countries, it ranked among the
commonest malignancies in males in our series (Table 3).
Tobacco smoking is a major risk factor in the development
of bladder cancer and the risk of developing bladder cancer
is several times higher in smokers than in non-smokers.
Like lung cancer, the risk is also proportionate with the
number of cigarettes smoked and the duration of smoking.
(Brennan et al., 2000; Negri and La Vecchia, 2001)
Prostate cancer was the tenth commonest cancer in
males comprising 4.8% (Table 3). It is the sixth most
common cancer worldwide(Parkin, 2001) comprising
9.7% of all cancers in males. It is more common in the
developed countries comprising over 15% and less so
in the developing countries comprising over 4% of all
cancers in males. According to US cancer statistics, it
was the commonest cancer in males comprising 28% and

second commonest cause of death from cancer in males
comprising 11% of all cancer deaths in males. However,
both the incidence and death rates from prostate cancer
have declined in the US.(Jemal et al., 2010) Italian
cancer figures 2006 also demonstrated a decrease in
mortality from prostate cancer.(AIRT Working Group)
In India, prostate cancer ranked among the most common
malignancies in males especially in the largest Indian
cities like Mumbai, Delhi, Kolkata and Bangalore. Indian
registries show a statistically significant increase in the
incidence rate of prostate cancer.(Jain et al., 2014) It has
a lower fatality rate compared to most other cancers and
accounts for 5.6% of all cancer deaths in males. Survival
rates in prostatic cancer are much higher in the developed
countries.(Brawley, 1997) In our series, almost 78%
patients were above 60 years of age. Worldwide, over 75%
prostate cancers occur above 65 years of age.(Epstein et
al., 2004)
The more common malignant tumors encountered
in our practice have been discussed. It is hoped that this
study will be an important step towards developing a
comprehensive cancer registry in Pakistan.
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